LH Stock Chart & Stats
$4705.14
$0.00(0.00%)
At close: 4:00 PM EDT
$4705.14
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$3,000.00 - $5,245.61
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
$430.78B
Enterprise ValueN/A
Total Cash (Recent Filing)$981.10M
Total Debt (Recent Filing)$7.24B
Price to Earnings (P/E)27.6
Beta0.15
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)11.37
Shares Outstanding82,000,000
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio1.28
Price to Book (P/B)2.42
Price to Sales (P/S)1.50
P/FCF Ratio17.31
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$5,480.10Price Target Upside16.47% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Labcorp Holdings News
LH FAQ
What was Labcorp Holdings’s price range in the past 12 months?
Labcorp Holdings lowest stock price was $3000.00 and its highest was $5245.61 in the past 12 months.
What is Labcorp Holdings’s market cap?
Labcorp Holdings’s market cap is $430.78B.
When is Labcorp Holdings’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Labcorp Holdings’s earnings last quarter?
Labcorp Holdings released its earnings results on Apr 30, 2026. The company reported $74.095 earnings per share for the quarter, beating the consensus estimate of $71.654 by $2.441.
Is Labcorp Holdings overvalued?
According to Wall Street analysts Labcorp Holdings’s price is currently Undervalued.
Does Labcorp Holdings pay dividends?
Labcorp Holdings does not currently pay dividends.
What is Labcorp Holdings’s EPS estimate?
Labcorp Holdings’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Labcorp Holdings have?
Labcorp Holdings has 82,000,000 shares outstanding.
What happened to Labcorp Holdings’s price movement after its last earnings report?
Labcorp Holdings reported an EPS of $74.095 in its last earnings report, beating expectations of $71.654. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Labcorp Holdings?
Currently, no hedge funds are holding shares in MX:LH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Labcorp Holdings Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$5,480.10 (16.47% Upside)
$5,480.10 (16.47% Upside)
Blogger Sentiment
Bullish
MX:LH Sentiment 100%
Sector Average 65%
Sector Average 65%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
12.03%
12-Months-Change
Fundamentals
Return on Equity
1.11%
Trailing 12-Months
Asset Growth
8.43%
Trailing 12-Months
Company Description
Labcorp Holdings
Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.
LH Company Deck
LH Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented a predominately positive picture: solid top-line growth, double-digit EPS improvement, margin expansion, healthy BLS backlog and raised/narrowed guidance. Management highlighted strong progress on strategic partnerships, product launches and AI/technology initiatives. Key challenges include weather-driven volume disruption, Early Development transitional actions, regulatory/reimbursement uncertainty (CRUSH, PAMA/RESULTS Act), and modest short-term cash flow/leverage considerations. Overall, positives around organic growth, profitability and a robust deal/product pipeline outweigh the identified headwinds.View all MX:LH earnings summariesLH Revenue Breakdown
77.96% Dx
22.21% BLS
-0.16% Intercompany eliminations

LH Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
$5,480.10
▲(16.47% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month








